$NEO
NEOGENOMICS INC Stock $neo

$neo Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000107718321000237 Filed on November 04, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2021 Q2
Revenue	$125.7M	$121.3M	$121.7M
YoY Change	-0.21%	-3.27%	39.95%
Cost Of Revenue	$80.48M	$74.10M	$68.73M
YoY Change	17.48%	3.81%	16.56%
Gross Profit	$45.26M	$47.24M	$52.99M
YoY Change	-21.29%	-12.63%	89.21%
Gross Profit Margin	35.99%	38.93%	43.53%
Selling, General & Admin	$67.50M	$79.54M	$71.86M
YoY Change	43.0%	67.7%	60.38%
% of Gross Profit	149.14%	168.38%	135.61%
Research & Development	$8.513M	$7.409M	$3.495M
YoY Change	305.38%	277.24%	66.03%
% of Gross Profit	18.81%	15.68%	6.6%
Depreciation & Amortization	$16.86M	$16.65M	$10.70M
YoY Change	75.28%	85.02%	27.21%
% of Gross Profit	37.26%	35.25%	20.19%
Operating Expenses	$84.49M	$86.95M	$75.36M
YoY Change	63.1%	76.03%	60.63%
Operating Profit	-$39.23M	-$39.71M	-$22.37M
YoY Change	-788.23%	-950.57%	18.3%
Interest Expense	-$1.707M	$1.296M	$902.0K
YoY Change	-22.41%	-47.27%	-41.73%
% of Operating Profit
Other Income/Expense, Net	-$930.0K	$89.00K	$171.0K
YoY Change	-122.14%	709.09%	-97.69%
Pretax Income	-$44.20M	-$23.17M	$73.44M
YoY Change	-681.63%	-1142.75%	-508.98%
Income Tax	-$2.445M	-$2.822M	-$2.437M
% Of Pretax Income			-3.32%
Net Earnings	-$41.76M	-$20.35M	$75.87M
YoY Change	-371.16%	-895.78%	-1211.86%
Net Earnings / Revenue	-33.21%	-16.77%	62.33%
Basic Earnings Per Share
Diluted Earnings Per Share	-$340.6K	-$166.0K	$578.1K
COMMON SHARES
Basic Shares Outstanding	123.1M shares	122.6M shares	118.3M shares
Diluted Shares Outstanding		122.6M shares	131.2M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$515.4M	$542.7M	$571.7M
YoY Change	73.97%	91.36%	93.62%
Cash & Equivalents	$316.8M	$340.6M	$368.8M
Short-Term Investments	$198.6M	$202.1M	$203.0M
Other Short-Term Assets	$8.189M	$15.76M	$8.422M
YoY Change	79.78%	297.05%	39.76%
Inventory	$23.40M	$21.83M	$21.38M
Prepaid Expenses	$12.35M	$14.62M	$13.96M
Receivables	$112.1M	$105.0M	$106.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$681.5M	$709.9M	$721.8M
YoY Change	51.87%	68.08%	72.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$109.5M	$107.2M	$112.2M
YoY Change	27.47%	25.42%	33.63%
Goodwill	$527.1M	$525.8M	$500.0M
YoY Change	149.72%	149.43%	137.18%
Intangibles	$442.3M	$450.8M	$471.0M
YoY Change	266.61%	265.46%	274.37%
Long-Term Investments	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Assets	$7.168M	$7.210M	$7.674M
YoY Change	59.18%	88.89%	151.03%
Total Long-Term Assets	$1.188B	$1.196B	$1.175B
YoY Change	120.21%	122.78%	123.09%
TOTAL ASSETS
Total Short-Term Assets	$681.5M	$709.9M	$721.8M
Total Long-Term Assets	$1.188B	$1.196B	$1.175B
Total Assets	$1.870B	$1.906B	$1.896B
YoY Change	89.19%	98.7%	100.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.92M	$28.54M	$23.06M
YoY Change	-28.22%	60.9%	20.1%
Accrued Expenses	$62.98M	$57.36M	$69.67M
YoY Change	52.5%	45.21%	101.93%
Deferred Revenue	$5.192M	$5.278M	$4.497M
YoY Change	28.87%	42.03%	25.97%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.135M	$1.564M	$1.913M
YoY Change
Total Short-Term Liabilities	$87.23M	$92.74M	$99.13M
YoY Change	19.2%	43.53%	60.67%
LONG-TERM LIABILITIES
Long-Term Debt	$532.6M	$531.9M	$531.5M
YoY Change	214.93%	217.0%	219.23%
Other Long-Term Liabilities	$14.02M	$14.43M	$3.796M
YoY Change	245.71%	266.57%	20.32%
Total Long-Term Liabilities	$674.3M	$676.4M	$648.8M
YoY Change	205.3%	196.08%	182.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.23M	$92.74M	$99.13M
Total Long-Term Liabilities	$674.3M	$676.4M	$648.8M
Total Liabilities	$761.5M	$769.1M	$748.0M
YoY Change	158.98%	162.45%	156.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.84M	$26.92M	$47.27M
YoY Change	106.5%	-219.11%	-287.89%
Common Stock	$1.124B	$1.111B	$1.101B
YoY Change	60.21%	61.23%	62.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.108B	$1.137B	$1.148B
YoY Change
Total Liabilities & Shareholders Equity	$1.870B	$1.906B	$1.896B
YoY Change	89.19%	98.7%	100.56%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021 Q2
OPERATING ACTIVITIES
Net Income	-$41.76M	-$20.35M	$75.87M
YoY Change	-371.16%	-895.78%	-1211.86%
Depreciation, Depletion And Amortization	$16.86M	$16.65M	$10.70M
YoY Change	75.28%	85.02%	27.21%
Cash From Operating Activities	-$19.78M	-$7.767M	-$1.390M
YoY Change	-430.15%	-1593.65%	-173.94%
INVESTING ACTIVITIES
Capital Expenditures	-$11.99M	-$14.98M	-$21.35M
YoY Change	4.14%	90.55%	325.26%
Acquisitions
YoY Change
Other Investing Activities	$2.404M	$291.0K	-$432.1M
YoY Change	-113.86%	-100.46%	3188.13%
Cash From Investing Activities	-$9.583M	-$14.69M	-$453.4M
YoY Change	-66.78%	-79.23%	2396.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.460M	-6.720M	204.6M
YoY Change	-70.25%	-263.5%	-8.08%
NET CHANGE
Cash From Operating Activities	-19.78M	-7.767M	-1.390M
Cash From Investing Activities	-9.583M	-14.69M	-453.4M
Cash From Financing Activities	2.460M	-6.720M	204.6M
Net Change In Cash	-26.90M	-29.17M	-250.2M
YoY Change	84.37%	-55.86%	-221.26%
FREE CASH FLOW
Cash From Operating Activities	-$19.78M	-$7.767M	-$1.390M
Capital Expenditures	-$11.99M	-$14.98M	-$21.35M
Free Cash Flow	-$7.789M	$7.210M	$19.96M
YoY Change	-144.51%	-13.96%	189.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001077183
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35756
	dei	Entity Registrant Name EntityRegistrantName	NEOGENOMICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-2897368
	dei	Entity Address Address Line1 EntityAddressAddressLine1	12701 Commonwealth Drive,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 9,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Myers,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33913
	dei	City Area Code CityAreaCode	(239)
	dei	Local Phone Number LocalPhoneNumber	768-0600
	dei	Security12b Title Security12bTitle	Common stock ($0.001 par value)
	dei	Trading Symbol TradingSymbol	NEO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	123122449	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	340565000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228713000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	202144000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	67546000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104964000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106843000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	21834000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	29526000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	14618000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11547000	USD
CY2021Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	10050000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	15755000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4555000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	709930000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	448730000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	112185000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	92895000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107172000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85873000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	102310000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45786000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	450802000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	120653000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	525802000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	211083000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3161000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	21919000	USD
CY2021Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	29555000	USD
CY2021Q3	neo	Prepaid Rent Noncurrent PrepaidRentNoncurrent	0	USD
CY2020Q4	neo	Prepaid Rent Noncurrent PrepaidRentNoncurrent	20229000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7210000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4503000	USD
CY2021Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1196457000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	539601000	USD
CY2021Q3	us-gaap	Assets Assets	1906387000	USD
CY2020Q4	us-gaap	Assets Assets	988331000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	28536000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	24965000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32283000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24727000	USD
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18088000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	11654000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1564000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2841000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6988000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4967000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5278000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4029000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	92737000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73183000	USD
CY2021Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	531779000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	168120000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	152000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	967000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72336000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42296000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	57706000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5415000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14432000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4056000	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	676405000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	220854000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	769142000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	294037000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123217010	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123217010	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112075474	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112075474	shares
CY2021Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	123000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	112000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1110590000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	701357000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-390000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	26922000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7185000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1137245000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	694294000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1906387000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	988331000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	121340000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125444000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	358597000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	318451000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	74101000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71379000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	216794000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	190011000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	47239000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	54065000	USD
	us-gaap	Gross Profit GrossProfit	141803000	USD
	us-gaap	Gross Profit GrossProfit	128440000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63839000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36128000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	158953000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107085000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7409000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1964000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13360000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6129000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15704000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11304000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46677000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34757000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	86952000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	49396000	USD
	us-gaap	Operating Expenses OperatingExpenses	218990000	USD
	us-gaap	Operating Expenses OperatingExpenses	147971000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39713000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	4669000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-77187000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19531000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1296000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2458000	USD
	us-gaap	Interest Expense InterestExpense	3375000	USD
	us-gaap	Interest Expense InterestExpense	4825000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	431000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7639000	USD
CY2021Q3	neo	Gain Loss On Investment And Loan Receivable GainLossOnInvestmentAndLoanReceivable	17750000	USD
CY2020Q3	neo	Gain Loss On Investment And Loan Receivable GainLossOnInvestmentAndLoanReceivable	0	USD
	neo	Gain Loss On Investment And Loan Receivable GainLossOnInvestmentAndLoanReceivable	109260000	USD
	neo	Gain Loss On Investment And Loan Receivable GainLossOnInvestmentAndLoanReceivable	0	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1400000	USD
CY2021Q3	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
CY2020Q3	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	-3506000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23170000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2222000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29129000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21623000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2822000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-335000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4283000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10378000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2557000	USD
	us-gaap	Net Income Loss NetIncomeLoss	33412000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11245000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2557000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33412000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11245000	USD
CY2021Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2020Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1975000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4532000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	33412000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11245000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.28
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122559000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110461000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119087000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107605000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122559000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119191000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121356000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107605000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2557000	USD
	us-gaap	Net Income Loss NetIncomeLoss	33412000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11245000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-57000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-21000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-21000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-1000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2661000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-57000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-21000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-400000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1640000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20405000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2536000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33012000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9605000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	694294000	USD
CY2021Q1	neo	Adjustments To Additional Paid In Capital Decrease From Purchase Of Calls Related To Convertible Debt AdjustmentsToAdditionalPaidInCapitalDecreaseFromPurchaseOfCallsRelatedToConvertibleDebt	29291000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1024000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-614000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2239000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	218500000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	242000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	241000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2412000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-160000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-22114000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	843714000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1245000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-163000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4430000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	189863000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	29175000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	102000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	298000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4208000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-183000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	75873000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1148358000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1020000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-304000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3374000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	35000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	236000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5001000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-57000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20348000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1137245000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	507408000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	796000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-212000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2897000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	194000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1991000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-1038000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-6978000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	505043000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	928000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-824000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2014000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	127293000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	209000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	211000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2424000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	30912000	USD
CY2020Q2	neo	Adjustments To Additional Paid In Capital Convertible Notes Issued Tax Liability AdjustmentsToAdditionalPaidInCapitalConvertibleNotesIssuedTaxLiability	9330000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	38000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2661000	USD
CY2020Q2	neo	Adjustments To Additional Paid In Capital Convertible Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalConvertibleStockIssuedIssuanceCosts	108000	USD
CY2020Q2	neo	Adjustments To Additional Paid In Capital Convertible Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalConvertibleStockIssuedIssuanceCosts	108000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6824000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	654229000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	808000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-237000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4846000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	29000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	222000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2494000	USD
CY2020Q3	neo	Adjustments To Additional Paid In Capital Tax Liability Component Of Convertible Debt Subsequent Adjustment AdjustmentsToAdditionalPaidInCapitalTaxLiabilityComponentOfConvertibleDebtSubsequentAdjustment	1524000	USD
CY2020Q3	neo	Adjustments To Additional Paid In Capital Convertible Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalConvertibleStockIssuedIssuanceCosts	30000	USD
CY2020Q3	neo	Adjustments To Additional Paid In Capital Convertible Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalConvertibleStockIssuedIssuanceCosts	30000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-21000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2557000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	666363000	USD
	us-gaap	Net Income Loss NetIncomeLoss	33412000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11245000	USD
	us-gaap	Depreciation Depreciation	21807000	USD
	us-gaap	Depreciation Depreciation	18705000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14683000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7387000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12396000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7536000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	6167000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	6365000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1904000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2705000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	133000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	138000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1400000	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	-3506000	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	109260000	USD
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	USD
	neo	Receivable With Imputed Interest Non Consolidated Affiliates ReceivableWithImputedInterestNonConsolidatedAffiliates	391000	USD
	neo	Receivable With Imputed Interest Non Consolidated Affiliates ReceivableWithImputedInterestNonConsolidatedAffiliates	0	USD
	neo	Polymerase Chain Reaction Testing Exit Costs Covid19 PolymeraseChainReactionTestingExitCostsCOVID19	6061000	USD
	neo	Polymerase Chain Reaction Testing Exit Costs Covid19 PolymeraseChainReactionTestingExitCostsCOVID19	0	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1388000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	371000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2475000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9455000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3196000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5704000	USD
	neo	Increase Decrease In Prepaid Construction IncreaseDecreaseInPrepaidConstruction	4435000	USD
	neo	Increase Decrease In Prepaid Construction IncreaseDecreaseInPrepaidConstruction	10142000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11796000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6757000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	15313000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-9335000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6947000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4525000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	180961000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	53396000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	44736000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52155000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17591000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	419404000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	37000000	USD
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	15000000	USD
	neo	Long Term Line Of Credit Settlement Gain Loss LongTermLineOfCreditSettlementGainLoss	4700000	USD
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	0	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	25600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-622784000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130587000	USD
	neo	Repayments Of Equipment And Other Finance Obligation RepaymentsOfEquipmentAndOtherFinanceObligation	2537000	USD
	neo	Repayments Of Equipment And Other Finance Obligation RepaymentsOfEquipmentAndOtherFinanceObligation	4331000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	97540000	USD
	neo	Derivative Termination Fee DerivativeTerminationFee	0	USD
	neo	Derivative Termination Fee DerivativeTerminationFee	3317000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12110000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10761000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	334410000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	194466000	USD
	neo	Payments Of Premiums For Capped Call Confirmations PaymentsOfPremiumsForCappedCallConfirmations	29291000	USD
	neo	Payments Of Premiums For Capped Call Confirmations PaymentsOfPremiumsForCappedCallConfirmations	0	USD
	neo	Proceeds From Equity Offering Net ProceedsFromEquityOfferingNet	408133000	USD
	neo	Proceeds From Equity Offering Net ProceedsFromEquityOfferingNet	127293000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	722825000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	227332000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	93094000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	92220000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	250632000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	173016000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	343726000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	265236000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	340565000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233233000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3161000	USD
CY2020Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	32003000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	343726000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	265236000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1792000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1638000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	113000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	209000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	29174000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	428000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2184000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3521000	USD
CY2021Q2	neo	Polymerase Chain Reaction Testing Exit Costs Covid19 PolymeraseChainReactionTestingExitCostsCOVID19	6100000	USD
CY2021Q2	neo	Polymerase Chain Reaction Testing Write Offs Covid19 PolymeraseChainReactionTestingWriteOffsCOVID19	5300000	USD
CY2021Q2	neo	Polymerase Chain Reaction Testing General And Administrative Expenses Covid19 PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19	800000	USD
CY2021Q3	neo	Polymerase Chain Reaction Testing General And Administrative Expenses Covid19 PolymeraseChainReactionTestingGeneralAndAdministrativeExpensesCOVID19	0	USD
	neo	Grant Income Cares Act GrantIncomeCARESAct	7900000	USD
CY2020Q3	neo	Grant Income Cares Act GrantIncomeCARESAct	0	USD
CY2020Q4	neo	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	5900000	USD
CY2021Q3	neo	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	5900000	USD
CY2021Q3	neo	Employee Retention Tax Credit Cares Act EmployeeRetentionTaxCreditCARESAct	3700000	USD
	neo	Employee Retention Tax Credit Cares Act EmployeeRetentionTaxCreditCARESAct	4400000	USD
	neo	Employee Retention Tax Credit Cares Act EmployeeRetentionTaxCreditCARESAct	1100000	USD
CY2020Q3	neo	Employee Retention Tax Credit Cares Act EmployeeRetentionTaxCreditCARESAct	1100000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares its Consolidated Financial Statements in conformity with GAAP. These principles require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the Consolidated Financial Statements. Actual results and outcomes may differ from management’s estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these Consolidated Financial Statements include, but are not limited, to those related to revenues, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets and intangible assets, income taxes and valuation allowances, stock-based compensation, business combinations, and impairment analysis of goodwill. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected on the Consolidated Financial Statements prospectively from the date of the change in estimate.</span></div>
CY2021Q3	neo	Asset Held For Sale Square Feet Of Facility Owned AssetHeldForSaleSquareFeetOfFacilityOwned	43560	sqft
CY2021Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	10100000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18000000	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	202589000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	450000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	202144000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	67590000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	45000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	67546000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	500000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	200000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	75692000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	126452000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	202144000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	27041000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	40505000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	67546000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1859000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10315000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9910000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9984000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6558000	USD
CY2021Q3	neo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	64802000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	103428000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24104000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	79324000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6988000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72336000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y10D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	3211000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1747000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	7888000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	6024000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37682000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	23766000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	5773000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	5101000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	211083000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	525802000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	501371000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	50569000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	450802000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	156548000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35895000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	120653000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8474000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2468000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14683000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7387000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8457000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	33899000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	33899000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	33899000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	33798000	USD
CY2021Q3	neo	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	293403000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	437355000	USD
CY2021Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	1716000	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	3808000	USD
CY2021Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	533495000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	171928000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	531931000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	169087000	USD
CY2020Q2	neo	Debt Instrument Covenant Threshold Of Default Percent Of Owners Of Debt DebtInstrumentCovenantThresholdOfDefaultPercentOfOwnersOfDebt	0.25
CY2021Q3	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0507
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0491
CY2021Q3	neo	Longterm Debt And Finance Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year LongtermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	716000	USD
CY2021Q3	neo	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	930000	USD
CY2021Q3	neo	Longterm Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Two LongtermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	69000	USD
CY2021Q3	neo	Longterm Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Three LongtermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	1000	USD
CY2021Q3	neo	Longterm Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Four LongtermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	201250000	USD
CY2021Q3	neo	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	345000000	USD
CY2021Q3	neo	Longterm Debt And Finance Lease Obligations Including Current Maturities LongtermDebtAndFinanceLeaseObligationsIncludingCurrentMaturities	547966000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1564000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	13712000	USD
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	759000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	531931000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5200000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2700000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12400000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7500000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3785941	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	887332	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	48.19
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	931954	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	226411	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	31.73
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3514908	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.63
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1758830	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	18.19
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	Collection of consideration the Company expects to receive typically occurs within 30 to 90 days of billing for commercial insurance, Medicare and other governmental and self-pay payers and within 60 to 90 days of billing for client payers.
CY2021Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1903000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1643000	USD
CY2021Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	248000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	290000	USD
CY2021Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2151000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1933000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	126000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	185000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	953000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	970000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	900000	USD
CY2020Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	300000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	1079000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	1155000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5278000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4029000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	932000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	712000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6210000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4741000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	200000	USD
CY2021Q3	neo	Contract With Customer Asset Percent ContractWithCustomerAssetPercent	0.11
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1500000	USD
	neo	Increase Decrease In Contract With Customer Liability Percent IncreaseDecreaseInContractWithCustomerLiabilityPercent	0.31
	neo	Increase Decrease In Capitalized Contract Costs Percent IncreaseDecreaseInCapitalizedContractCostsPercent	-0.07
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	400000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4200000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2100000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	200000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	600000	USD
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	4500000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	121340000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125444000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	358597000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	318451000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2557000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	33412000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11245000	USD
CY2021Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2020Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1975000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3700000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4532000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	33412000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11245000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	122559000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	110461000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	119087000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	107605000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122559000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119191000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121356000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107605000	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2020Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000	USD
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.28
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
	neo	Defined Contribution Plan Employer Matching Additional Contribution Upon Employee Percent DefinedContributionPlanEmployerMatchingAdditionalContributionUponEmployeePercent	0.02
	neo	Defined Contribution Plan Additional Maximum Annual Contributions Per Employee Percent DefinedContributionPlanAdditionalMaximumAnnualContributionsPerEmployeePercent	0.04
CY2021Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1400000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	121340000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	125444000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	358597000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	318451000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	74101000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	71379000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	216794000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	190011000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	47239000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	54065000	USD
	us-gaap	Gross Profit GrossProfit	141803000	USD
	us-gaap	Gross Profit GrossProfit	128440000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63839000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36128000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	158953000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107085000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7409000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1964000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13360000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6129000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15704000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11304000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46677000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34757000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	86952000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	49396000	USD
	us-gaap	Operating Expenses OperatingExpenses	218990000	USD
	us-gaap	Operating Expenses OperatingExpenses	147971000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39713000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	4669000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-77187000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19531000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1296000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2458000	USD
	us-gaap	Interest Expense InterestExpense	3375000	USD
	us-gaap	Interest Expense InterestExpense	4825000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	431000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7639000	USD
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	17750000	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	-3506000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23170000	USD
CY2020Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	109260000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1400000	USD
CY2021Q3	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
CY2020Q3	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
	neo	Gain Loss On Termination Of Interest Rate Swap GainLossOnTerminationOfInterestRateSwap	0	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2222000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29129000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21623000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2822000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-335000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4283000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10378000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20348000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2557000	USD
	us-gaap	Net Income Loss NetIncomeLoss	33412000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11245000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30

Files In Submission

Name	View Source	Status
0001077183-21-000237-index-headers.html	Edgar Link	pending
0001077183-21-000237-index.html	Edgar Link	pending
0001077183-21-000237.txt	Edgar Link	pending
0001077183-21-000237-xbrl.zip	Edgar Link	pending
a09302021neo-ex311.htm	Edgar Link	pending
a09302021neo-ex312.htm	Edgar Link	pending
a09302021neo-ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gilbert-neogenomics_xemplo.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
neo-20210930.htm	Edgar Link	pending
neo-20210930.xsd	Edgar Link	pending
neo-20210930_cal.xml	Edgar Link	unprocessable
neo-20210930_def.xml	Edgar Link	unprocessable
neo-20210930_htm.xml	Edgar Link	completed
neo-20210930_lab.xml	Edgar Link	unprocessable
neo-20210930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEO
NEOGENOMICS INC Stock $neo

2021 Q4 Form 10-Q Financial Statement

#000107718321000237 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEO NEOGENOMICS INC Stock $neo

2021 Q4 Form 10-Q Financial Statement

#000107718321000237 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEO
NEOGENOMICS INC Stock $neo